Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 1
2004 2
2005 1
2007 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Bruce Psaty and the risks of calcium channel blockers.
Deyo RA. Deyo RA. Qual Saf Health Care. 2002 Sep;11(3):294-6. doi: 10.1136/qhc.11.3.294. Qual Saf Health Care. 2002. PMID: 12486998 Free PMC article. No abstract available.
Albrecht Fleckenstein: father of calcium antagonism.
Acierno LJ, Worrell LT. Acierno LJ, et al. Clin Cardiol. 2004 Dec;27(12):710-1. doi: 10.1002/clc.4960271213. Clin Cardiol. 2004. PMID: 15628117 Free PMC article. No abstract available.
Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. 1984.
Vogelgesang B, Echizen H, Schmidt E, Eichelbaum M. Vogelgesang B, et al. Br J Clin Pharmacol. 2004 Dec;58(7):S796-803; discussion S804-6. doi: 10.1111/j.1365-2125.2004.02299.x. Br J Clin Pharmacol. 2004. PMID: 15595975 Free PMC article. No abstract available.
[The discovery of calcium antagonists].
Goldmann S. Goldmann S. Pharm Unserer Zeit. 2005;34(5):366-73. doi: 10.1002/pauz.200500134. Pharm Unserer Zeit. 2005. PMID: 16180358 German. No abstract available.
Feedback